Status:
NOT_YET_RECRUITING
DELINEATE-Prospective
Lead Sponsor:
Columbia University
Collaborating Sponsors:
American Heart Association
Conditions:
Valve Disease, Aortic
Mitral Regurgitation (MR)
Eligibility:
All Genders
18+ years
Brief Summary
Heart disease is the leading cause of death in the United States, and echocardiography (or "echo") is the most common way doctors look at the heart. Echo is safe, painless, and can detect major heart ...
Detailed Description
In a prior Columbia University study, a series of deep learning algorithms analyzing echocardiograms is in development. These algorithms include, but are not limited to, algorithms that enable view cl...
Eligibility Criteria
Inclusion
- Attending cardiologist employed by Columbia University, ColumbiaDoctors, or NewYork Presbyterian Hospital who reads transthoracic echocardiograms in the Columbia echocardiography laboratory
- Provided informed consent to take part in the questionnaires or pivotal study
Exclusion
- Physician in training (cardiology fellow or advanced imaging fellow)
Key Trial Info
Start Date :
February 15 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2028
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07197736
Start Date
February 15 2026
End Date
October 1 2028
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Irving Medical Center
New York, New York, United States, 10032